Table 3.
Change of UACR before and after IVB
UACR | All Patients | Diabetic Patients | ||||
---|---|---|---|---|---|---|
Control | DM | P Value | NPDR | PDR | P Value | |
Geometric mean (95% CI) | ||||||
Pre-IVB | 9.0 | 94.4 | <0.001 | 64.6 | 136.1 | 0.130 |
(6.3–12.6) | (57.7–154.5) | (31.6–132.2) | (68.1–272.3) | |||
Post-IVB | 8.9 | 101.4 | <0.001 | 79.0 | 128.9 | 0.091 |
(6.7–11.7) | (62.3–165.1) | (39.8–156.7) | (62.4–266.5) | |||
P value* | 0.931 | 0.441 | 0.180 | 0.624 | ||
Abnormal albuminuria† | ||||||
Abnormal range at pre-IVB | 4 (11%) | 36 (68%) | <0.001 | 16 (62%) | 20 (74%) | 0.328 |
Abnormal range at post-IVB | 4 (11%) | 38 (72%) | <0.001 | 19 (73%) | 19 (70%) | 0.698 |
Data are expressed as number (percentage) unless otherwise stated.
P value by Wilcoxon signed rank test comparing pre-IVB and post-IVB data.
Abnormal range of UACR (≥ 30 mg/g).